<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34830074</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>22</Issue><PubDate><Year>2021</Year><Month>Nov</Month><Day>11</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Metals in ALS TDP-43 Pathology.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">12193</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms222212193</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS), Alzheimer's disease, Parkinson's disease and similar neurodegenerative disorders take their toll on patients, caregivers and society. A common denominator for these disorders is the accumulation of aggregated proteins in nerve cells, yet the triggers for these aggregation processes are currently unknown. In ALS, protein aggregation has been described for the SOD1, C9orf72, FUS and TDP-43 proteins. The latter is a nuclear protein normally binding to both DNA and RNA, contributing to gene expression and mRNA life cycle regulation. TDP-43 seems to have a specific role in ALS pathogenesis, and ubiquitinated and hyperphosphorylated cytoplasmic inclusions of aggregated TDP-43 are present in nerve cells in almost all sporadic ALS cases. ALS pathology appears to include metal imbalances, and environmental metal exposure is a known risk factor in ALS. However, studies on metal-to-TDP-43 interactions are scarce, even though this protein seems to have the capacity to bind to metals. This review discusses the possible role of metals in TDP-43 aggregation, with respect to ALS pathology.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Koski</LastName><ForeName>Lassi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Environmental Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ronnevi</LastName><ForeName>Cecilia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Capio St. G&#xf6;ran Hospital, 112 19 Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berntsson</LastName><ForeName>Elina</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Biophysics, Stockholm University, 106 91 Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry and Biotechnology, Tallinn University of Technology, 12616 Tallinn, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>W&#xe4;rml&#xe4;nder</LastName><ForeName>Sebastian K T S</ForeName><Initials>SKTS</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Biophysics, Stockholm University, 106 91 Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roos</LastName><ForeName>Per M</ForeName><Initials>PM</Initials><Identifier Source="ORCID">0000-0003-3202-9687</Identifier><AffiliationInfo><Affiliation>Institute of Environmental Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Capio St. G&#xf6;ran Hospital, 112 19 Stockholm, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>001</GrantID><Agency>Magnus Bergvall foundation</Agency><Country/></Grant><Grant><GrantID>001</GrantID><Agency>Kamprad Research Foundation</Agency><Country/></Grant><Grant><GrantID>001</GrantID><Agency>Ulla-Carin Lindquist Foundation for ALS Research</Agency><Country/></Grant><Grant><GrantID>001</GrantID><Agency>Karolinska Institutet IMM strategic grants</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599550">FUS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008670">Metals</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C531617">Amyotrophic lateral sclerosis 1</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004781" MajorTopicYN="N">Environmental Exposure</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008670" MajorTopicYN="Y">Metals</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066263" MajorTopicYN="N">Protein Aggregation, Pathological</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyloid</Keyword><Keyword MajorTopicYN="N">metal exposure</Keyword><Keyword MajorTopicYN="N">metallopathy</Keyword><Keyword MajorTopicYN="N">metal&#x2013;protein binding</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">protein aggregation</Keyword><Keyword MajorTopicYN="N">proteinopathy</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>27</Day><Hour>1</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34830074</ArticleId><ArticleId IdType="pmc">PMC8622279</ArticleId><ArticleId IdType="doi">10.3390/ijms222212193</ArticleId><ArticleId IdType="pii">ijms222212193</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kiernan M.C., Vucic S., Cheah B.C., Turner M.R., Eisen A., Hardiman O., Burrell J.R., Zoing M.C. Amyotrophic lateral sclerosis. Lancet. 2011;377:942&#x2013;955. doi: 10.1016/S0140-6736(10)61156-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown R.H., Al-Chalabi A. Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es M.A., Hardiman O., Chio A., Al-Chalabi A., Pasterkamp R.J., Veldink J.H., van den Berg L.H. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084&#x2013;2098. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., Hardiman O., Kiernan M.C., Chio A., Rix-Brooks B., van den Berg L.H. Amyotrophic lateral sclerosis: Moving towards a new classification system. Lancet Neurol. 2016;15:1182&#x2013;1194. doi: 10.1016/S1474-4422(16)30199-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(16)30199-5</ArticleId><ArticleId IdType="pubmed">27647646</ArticleId></ArticleIdList></Reference><Reference><Citation>Forman M.S., Trojanowski J.Q., Lee V.M. TDP-43: A novel neurodegenerative proteinopathy. Curr. Opin. Neurobiol. 2007;17:548&#x2013;555. doi: 10.1016/j.conb.2007.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2007.08.005</ArticleId><ArticleId IdType="pmc">PMC2678676</ArticleId><ArticleId IdType="pubmed">17936612</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingre C., Roos P.M., Piehl F., Kamel F., Fang F. Risk factors for amyotrophic lateral sclerosis. Clin. Epidemiol. 2015;7:181&#x2013;193. doi: 10.2147/CLEP.S37505.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S37505</ArticleId><ArticleId IdType="pmc">PMC4334292</ArticleId><ArticleId IdType="pubmed">25709501</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J., Wang L., Yan T., Perry G., Wang X. TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration. Mol. Cell Neurosci. 2019;100:103396. doi: 10.1016/j.mcn.2019.103396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2019.103396</ArticleId><ArticleId IdType="pmc">PMC6874890</ArticleId><ArticleId IdType="pubmed">31445085</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong M.J., Kesavapany S., Pant H.C. The pathobiology of amyotrophic lateral sclerosis: A proteinopathy? J. Neuropathol. Exp. Neurol. 2005;64:649&#x2013;664. doi: 10.1097/01.jnen.0000173889.71434.ea.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.jnen.0000173889.71434.ea</ArticleId><ArticleId IdType="pubmed">16106213</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R., Bigio E.H., Ince P.G., Geser F., Neumann M., Cairns N.J., Kwong L.K., Forman M.S., Ravits J., Stewart H., et al. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann. Neurol. 2007;61:427&#x2013;434. doi: 10.1002/ana.21147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21147</ArticleId><ArticleId IdType="pubmed">17469116</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell R.M., Freeman W.M., Randazzo W.T., Stephens H.E., Beard J.L., Simmons Z., Connor J.R. A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis. Neurology. 2009;72:14&#x2013;19. doi: 10.1212/01.wnl.0000333251.36681.a5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000333251.36681.a5</ArticleId><ArticleId IdType="pubmed">18987350</ArticleId></ArticleIdList></Reference><Reference><Citation>Bereman M.S., Beri J., Enders J.R., Nash T. Machine Learning Reveals Protein Signatures in CSF and Plasma Fluids of Clinical Value for ALS. Sci. Rep. 2018;8:16334. doi: 10.1038/s41598-018-34642-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-34642-x</ArticleId><ArticleId IdType="pmc">PMC6218542</ArticleId><ArticleId IdType="pubmed">30397248</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramstr&#xf6;m M., Ivonin I., Johansson A., Askmark H., Markides K.E., Zubarev R., H&#xe5;kansson P., Aquilonius S.M., Bergquist J. Cerebrospinal fluid protein patterns in neurodegenerative disease revealed by liquid chromatography-Fourier transform ion cyclotron resonance mass spectrometry. Proteomics. 2004;4:4010&#x2013;4018. doi: 10.1002/pmic.200400871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmic.200400871</ArticleId><ArticleId IdType="pubmed">15540204</ArticleId></ArticleIdList></Reference><Reference><Citation>Reijn T.S., Abdo W.F., Schelhaas H.J., Verbeek M.M. CSF neurofilament protein analysis in the differential diagnosis of ALS. J. Neurol. 2009;256:615&#x2013;619. doi: 10.1007/s00415-009-0131-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-009-0131-z</ArticleId><ArticleId IdType="pubmed">19296046</ArticleId></ArticleIdList></Reference><Reference><Citation>Katzeff J.S., Bright F., Lo K., Kril J.J., Connolly A., Crossett B., Ittner L.M., Kassiou M., Loy C.T., Hodges J.R., et al. Altered serum protein levels in frontotemporal dementia and amyotrophic lateral sclerosis indicate calcium and immunity dysregulation. Sci. Rep. 2020;10:13741. doi: 10.1038/s41598-020-70687-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-70687-7</ArticleId><ArticleId IdType="pmc">PMC7426269</ArticleId><ArticleId IdType="pubmed">32792518</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlary L., Chew Y.L., Lum J.S., Geraghty N.J., Yerbury J.J., Cashman N.R. Amyotrophic Lateral Sclerosis: Proteins, Proteostasis, Prions, and Promises. Front. Cell. Neurosci. 2020;14:581907. doi: 10.3389/fncel.2020.581907.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.581907</ArticleId><ArticleId IdType="pmc">PMC7671971</ArticleId><ArticleId IdType="pubmed">33328890</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulligan V.K., Kerman A., Laister R.C., Sharda P.R., Arslan P.E., Chakrabartty A. Early steps in oxidation-induced SOD1 misfolding: Implications for non-amyloid protein aggregation in familial ALS. J. Mol. Biol. 2012;421:631&#x2013;652. doi: 10.1016/j.jmb.2012.04.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2012.04.016</ArticleId><ArticleId IdType="pubmed">22542526</ArticleId></ArticleIdList></Reference><Reference><Citation>Parakh S., Atkin J.D. Protein folding alterations in amyotrophic lateral sclerosis. Brain Res. 2016;1648:633&#x2013;649. doi: 10.1016/j.brainres.2016.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.04.010</ArticleId><ArticleId IdType="pubmed">27064076</ArticleId></ArticleIdList></Reference><Reference><Citation>Blokhuis A.M., Groen E.J., Koppers M., van den Berg L.H., Pasterkamp R.J. Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol. 2013;125:777&#x2013;794. doi: 10.1007/s00401-013-1125-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1125-6</ArticleId><ArticleId IdType="pmc">PMC3661910</ArticleId><ArticleId IdType="pubmed">23673820</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K., Weng S.M., Arzberger T., May S., Rentzsch K., Kremmer E., Schmid B., Kretzschmar H.A., Cruts M., Van Broeckhoven C., et al. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science. 2013;339:1335&#x2013;1338. doi: 10.1126/science.1232927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1232927</ArticleId><ArticleId IdType="pubmed">23393093</ArticleId></ArticleIdList></Reference><Reference><Citation>Ticozzi N., Ratti A., Silani V. Protein aggregation and defective RNA metabolism as mechanisms for motor neuron damage. CNS Neurol. Disord. Drug Targets. 2010;9:285&#x2013;296. doi: 10.2174/187152710791292585.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/187152710791292585</ArticleId><ArticleId IdType="pubmed">20406182</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo X., Zhou J., Li Y., Wu K., Chen Z., Luo Z., Zhang X., Liang Y., Esteban M.A., Zhou Y., et al. TDP-43 aggregation induced by oxidative stress causes global mitochondrial imbalance in ALS. Nat. Struct. Mol. Biol. 2021;28:132&#x2013;142. doi: 10.1038/s41594-020-00537-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-020-00537-7</ArticleId><ArticleId IdType="pubmed">33398173</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng W., Aschner M., Ghersi-Egea J.F. Brain barrier systems: A new frontier in metal neurotoxicological research. Toxicol. Appl. Pharmacol. 2003;192:1&#x2013;11. doi: 10.1016/S0041-008X(03)00251-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0041-008X(03)00251-5</ArticleId><ArticleId IdType="pmc">PMC3982148</ArticleId><ArticleId IdType="pubmed">14554098</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney M.D., Sagare A.P., Zlokovic B.V. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat. Rev. Neurol. 2018;14:133&#x2013;150. doi: 10.1038/nrneurol.2017.188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2017.188</ArticleId><ArticleId IdType="pmc">PMC5829048</ArticleId><ArticleId IdType="pubmed">29377008</ArticleId></ArticleIdList></Reference><Reference><Citation>Roos P.M. Ultraclean paired sampling for metal analysis in neurodegenerative disorders. J. Trace Elem. Med. Biol. 2019;52:48&#x2013;52. doi: 10.1016/j.jtemb.2018.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtemb.2018.11.007</ArticleId><ArticleId IdType="pubmed">30732898</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O&#x2032;Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R., Chio A., Traynor B.J. Novel genes associated with amyotrophic lateral sclerosis: Diagnostic and clinical implications. Lancet Neurol. 2018;17:94&#x2013;102. doi: 10.1016/S1474-4422(17)30401-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30401-5</ArticleId><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim G., Gautier O., Tassoni-Tsuchida E., Ma X.R., Gitler A.D. ALS Genetics: Gains, Losses, and Implications for Future Therapies. Neuron. 2020;108:822&#x2013;842. doi: 10.1016/j.neuron.2020.08.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.08.022</ArticleId><ArticleId IdType="pmc">PMC7736125</ArticleId><ArticleId IdType="pubmed">32931756</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka T., Hasegawa M. TDP-43 Prions. Cold Spring Harb. Perspect. Med. 2018;8:a024463. doi: 10.1101/cshperspect.a024463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a024463</ArticleId><ArticleId IdType="pmc">PMC5830907</ArticleId><ArticleId IdType="pubmed">28108532</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J., Wang L., Huntley M.L., Perry G., Wang X. Pathomechanisms of TDP-43 in neurodegeneration. J. Neurochem. 2018;146:7&#x2013;20. doi: 10.1111/jnc.14327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14327</ArticleId><ArticleId IdType="pmc">PMC6110993</ArticleId><ArticleId IdType="pubmed">29486049</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti A., Buratti E. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins. J. Neurochem. 2016;138:95&#x2013;111. doi: 10.1111/jnc.13625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13625</ArticleId><ArticleId IdType="pubmed">27015757</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 2006;351:602&#x2013;611. doi: 10.1016/j.bbrc.2006.10.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668&#x2013;1672. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Berning B.A., Walker A.K. The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD. Front. Neurosci. 2019;13:335. doi: 10.3389/fnins.2019.00335.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00335</ArticleId><ArticleId IdType="pmc">PMC6470282</ArticleId><ArticleId IdType="pubmed">31031584</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf6;r&#xdf; D., Kilimann I., Dyrba M., Nitsch S., Krause B., Teipel S. LATE: Nicht jede Demenz ist Alzheimer&#x2014;Diskussion einer neuen Krankheitsentit&#xe4;t am Fallbeispiel. Nervenarzt. 2021;92:18&#x2013;26. doi: 10.1007/s00115-020-00922-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00115-020-00922-z</ArticleId><ArticleId IdType="pmc">PMC7809002</ArticleId><ArticleId IdType="pubmed">32409844</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuller-Thomson E., Deng Z. Could Lifetime Lead Exposure Play a Role in Limbic-predominant Age-related TDP-43 Encephalopathy (LATE)? J. Alzheimer&#x2019;s Dis. 2020;73:455&#x2013;459. doi: 10.3233/JAD-190943.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-190943</ArticleId><ArticleId IdType="pubmed">31815698</ArticleId></ArticleIdList></Reference><Reference><Citation>Hergesheimer R.C., Chami A.A., de Assis D.R., Vourc&#x2032;h P., Andres C.R., Corcia P., Lanznaster D., Blasco H. The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: A resolution in sight? Brain. 2019;142:1176&#x2013;1194. doi: 10.1093/brain/awz078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz078</ArticleId><ArticleId IdType="pmc">PMC6487324</ArticleId><ArticleId IdType="pubmed">30938443</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad A., Bharathi V., Sivalingam V., Girdhar A., Patel B.K. Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci. 2019;12:25. doi: 10.3389/fnmol.2019.00025.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00025</ArticleId><ArticleId IdType="pmc">PMC6382748</ArticleId><ArticleId IdType="pubmed">30837838</ArticleId></ArticleIdList></Reference><Reference><Citation>Winton M.J., Igaz L.M., Wong M.M., Kwong L.K., Trojanowski J.Q., Lee V.M. Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J. Biol. Chem. 2008;283:13302&#x2013;13309. doi: 10.1074/jbc.M800342200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M800342200</ArticleId><ArticleId IdType="pmc">PMC2442318</ArticleId><ArticleId IdType="pubmed">18305110</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakagawa Y., Yamada S. A novel hypothesis on metal dyshomeostasis and mitochondrial dysfunction in amyotrophic lateral sclerosis: Potential pathogenetic mechanism and therapeutic implications. Eur. J. Pharmacol. 2021;892:173737. doi: 10.1016/j.ejphar.2020.173737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2020.173737</ArticleId><ArticleId IdType="pubmed">33220280</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozzo F., Mirra A., Carri M.T. Oxidative stress and mitochondrial damage in the pathogenesis of ALS: New perspectives. Neurosci. Lett. 2017;636:3&#x2013;8. doi: 10.1016/j.neulet.2016.04.065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2016.04.065</ArticleId><ArticleId IdType="pubmed">27150074</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash P.E.A., Dhawan U., Boudeau S., Lei S., Carlomagno Y., Knobel M., Al Mohanna L.F.A., Boomhower S.R., Newland M.C., Sherr D.H., et al. Heavy Metal Neurotoxicants Induce ALS-Linked TDP-43 Pathology. Toxicol. Sci. 2019;167:105&#x2013;115. doi: 10.1093/toxsci/kfy267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/toxsci/kfy267</ArticleId><ArticleId IdType="pmc">PMC6317426</ArticleId><ArticleId IdType="pubmed">30371865</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimer&#x2032;s-Association Alzheimer&#x2032;s disease facts and figures. Alzheimer&#x2032;s Dement. 2021;17:327&#x2013;406. doi: 10.1002/alz.12328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12328</ArticleId><ArticleId IdType="pubmed">33756057</ArticleId></ArticleIdList></Reference><Reference><Citation>Melo F., Caballero L., Zamorano E., Ventura N., Navarro C., Doll I., Zamorano P., Cornejo A. The Cytotoxic Effect of alpha-Synuclein Aggregates. ChemPhysChem. 2021;22:526&#x2013;532. doi: 10.1002/cphc.202000831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cphc.202000831</ArticleId><ArticleId IdType="pubmed">33482036</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocha Cabrero F., Morrison E.H. StatPearls. StatPearls Publishing; Treasure Island, FL, USA: 2021. Lewy Bodies.</Citation></Reference><Reference><Citation>Saa P., Harris D.A., Cervenakova L. Mechanisms of prion-induced neurodegeneration. Expert Rev. Mol. Med. 2016;18:e5. doi: 10.1017/erm.2016.8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/erm.2016.8</ArticleId><ArticleId IdType="pubmed">27055367</ArticleId></ArticleIdList></Reference><Reference><Citation>Prusiner S.B. Nobel Lecture: Prions. Proc. Natl. Acad. Sci. USA. 1998;95:13363&#x2013;13383. doi: 10.1073/pnas.95.23.13363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.95.23.13363</ArticleId><ArticleId IdType="pmc">PMC33918</ArticleId><ArticleId IdType="pubmed">9811807</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera F., Tenreiro S., Miller-Fleming L., Outeiro T.F. Visualization of cell-to-cell transmission of mutant huntingtin oligomers. PLoS Curr. 2011;3:RRN1210. doi: 10.1371/currents.RRN1210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/currents.RRN1210</ArticleId><ArticleId IdType="pmc">PMC3037516</ArticleId><ArticleId IdType="pubmed">21331289</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J., Blum T.B., Farrell D.P., DiMaio F., Abrahams J.P., Luo J. Cryo-electron Microscopy Imaging of Alzheimer&#x2019;s Amyloid-beta 42 Oligomer Displayed on a Functionally and Structurally Relevant Scaffold. Angew. Chem. Int. Ed. Engl. 2021;60:18680&#x2013;18687. doi: 10.1002/anie.202104497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.202104497</ArticleId><ArticleId IdType="pmc">PMC8457241</ArticleId><ArticleId IdType="pubmed">34042235</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo J., W&#xe4;rml&#xe4;nder S.K., Gr&#xe4;slund A., Abrahams J.P. Alzheimer peptides aggregate into transient nanoglobules that nucleate fibrils. Biochemistry. 2014;53:6302&#x2013;6308. doi: 10.1021/bi5003579.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi5003579</ArticleId><ArticleId IdType="pubmed">25198136</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhazmi H.A., Ahsan W., Ibrahim A.M.M., Khubrani R.A.Y., Haddadi Z.A.A., Safhi A.Y.F., Shubayr N., Al Bratty M., Najmi A. Investigation of bovine serum albumin aggregation upon exposure to silver(I) and copper(II) metal ions using Zetasizer. Open Chem. 2021;19:987&#x2013;997. doi: 10.1515/chem-2021-0089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/chem-2021-0089</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallin C., Jarvet J., Biverst&#xe5;l H., W&#xe4;rml&#xe4;nder S., Danielsson J., Gr&#xe4;slund A., Abelein A. Metal ion coordination delays amyloid-beta peptide self-assembly by forming an aggregation-inert complex. J. Biol. Chem. 2020;295:7224&#x2013;7234. doi: 10.1074/jbc.RA120.012738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA120.012738</ArticleId><ArticleId IdType="pmc">PMC7247290</ArticleId><ArticleId IdType="pubmed">32241918</ArticleId></ArticleIdList></Reference><Reference><Citation>Berntsson E., Paul S., Vosough F., Sholts S.B., Jarvet J., Roos P.M., Barth A., Gr&#xe4;slund A., W&#xe4;rml&#xe4;nder S. Lithium ions display weak interaction with amyloid-beta (Abeta) peptides and have minor effects on their aggregation. Acta Biochim. Pol. 2021;68:169&#x2013;179. doi: 10.18388/abp.2020_5493.</Citation><ArticleIdList><ArticleId IdType="doi">10.18388/abp.2020_5493</ArticleId><ArticleId IdType="pubmed">33909969</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisenberg D., Jucker M. The amyloid state of proteins in human diseases. Cell. 2012;148:1188&#x2013;1203. doi: 10.1016/j.cell.2012.02.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.02.022</ArticleId><ArticleId IdType="pmc">PMC3353745</ArticleId><ArticleId IdType="pubmed">22424229</ArticleId></ArticleIdList></Reference><Reference><Citation>Abelein A., Abrahams J.P., Danielsson J., Gr&#xe4;slund A., Jarvet J., Luo J., Tiiman A., W&#xe4;rml&#xe4;nder S.K. The hairpin conformation of the amyloid beta peptide is an important structural motif along the aggregation pathway. J. Biol. Inorg. Chem. 2014;19:623&#x2013;634. doi: 10.1007/s00775-014-1131-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00775-014-1131-8</ArticleId><ArticleId IdType="pubmed">24737040</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha M.S., Ansell-Schultz A., Civitelli L., Hildesjo C., Larsson M., Lannfelt L., Ingelsson M., Hallbeck M. Alzheimer&#x2032;s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers. Acta Neuropathol. 2018;136:41&#x2013;56. doi: 10.1007/s00401-018-1868-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1868-1</ArticleId><ArticleId IdType="pmc">PMC6015111</ArticleId><ArticleId IdType="pubmed">29934873</ArticleId></ArticleIdList></Reference><Reference><Citation>Armen R.S., DeMarco M.L., Alonso D.O., Daggett V. Pauling and Corey&#x2019;s alpha-pleated sheet structure may define the prefibrillar amyloidogenic intermediate in amyloid disease. Proc. Natl. Acad. Sci. USA. 2004;101:11622&#x2013;11627. doi: 10.1073/pnas.0401781101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0401781101</ArticleId><ArticleId IdType="pmc">PMC511030</ArticleId><ArticleId IdType="pubmed">15280548</ArticleId></ArticleIdList></Reference><Reference><Citation>W&#xe4;rml&#xe4;nder S.K.T.S., &#xd6;sterlund N., Wallin C., Wu J., Luo J., Tiiman A., Jarvet J., Gr&#xe4;slund A. Metal binding to the amyloid-beta peptides in the presence of biomembranes: Potential mechanisms of cell toxicity. J. Biol. Inorg. Chem. 2019;24:1189&#x2013;1196. doi: 10.1007/s00775-019-01723-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00775-019-01723-9</ArticleId><ArticleId IdType="pubmed">31562546</ArticleId></ArticleIdList></Reference><Reference><Citation>Owen M.C., Gnutt D., Gao M., W&#xe4;rml&#xe4;nder S.K.T.S., Jarvet J., Gr&#xe4;slund A., Winter R., Ebbinghaus S., Strodel B. Effects of in vivo conditions on amyloid aggregation. Chem. Soc. Rev. 2019;48:3946&#x2013;3996. doi: 10.1039/C8CS00034D.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C8CS00034D</ArticleId><ArticleId IdType="pubmed">31192324</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallin C., Sholts S.B., &#xd6;sterlund N., Luo J., Jarvet J., Roos P.M., Ilag L., Gr&#xe4;slund A., W&#xe4;rml&#xe4;nder S.K.T.S. Alzheimer&#x2019;s disease and cigarette smoke components: Effects of nicotine, PAHs, and Cd(II), Cr(III), Pb(II), Pb(IV) ions on amyloid-beta peptide aggregation. Sci. Rep. 2017;7:14423. doi: 10.1038/s41598-017-13759-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-13759-5</ArticleId><ArticleId IdType="pmc">PMC5663743</ArticleId><ArticleId IdType="pubmed">29089568</ArticleId></ArticleIdList></Reference><Reference><Citation>W&#xe4;rml&#xe4;nder S., Tiiman A., Abelein A., Luo J., Jarvet J., S&#xf6;derberg K.L., Danielsson J., Gr&#xe4;slund A. Biophysical studies of the amyloid beta-peptide: Interactions with metal ions and small molecules. ChemBioChem. 2013;14:1692&#x2013;1704. doi: 10.1002/cbic.201300262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbic.201300262</ArticleId><ArticleId IdType="pubmed">23983094</ArticleId></ArticleIdList></Reference><Reference><Citation>Caragounis A., Price K.A., Soon C.P., Filiz G., Masters C.L., Li Q.X., Crouch P.J., White A.R. Zinc induces depletion and aggregation of endogenous TDP-43. Free Radic. Biol. Med. 2010;48:1152&#x2013;1161. doi: 10.1016/j.freeradbiomed.2010.01.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2010.01.035</ArticleId><ArticleId IdType="pubmed">20138212</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo J., Warmlander S.K., Graslund A., Abrahams J.P. Cross-interactions between the Alzheimer Disease Amyloid-beta Peptide and Other Amyloid Proteins: A Further Aspect of the Amyloid Cascade Hypothesis. J. Biol. Chem. 2016;291:16485&#x2013;16493. doi: 10.1074/jbc.R116.714576.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.R116.714576</ArticleId><ArticleId IdType="pmc">PMC4974365</ArticleId><ArticleId IdType="pubmed">27325705</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathi P., Rodriguez-Muela N., Klim J.R., de Boer A.S., Agrawal S., Sandoe J., Lopes C.S., Ogliari K.S., Williams L.A., Shear M., et al. Reactive Astrocytes Promote ALS-like Degeneration and Intracellular Protein Aggregation in Human Motor Neurons by Disrupting Autophagy through TGF-beta1. Stem. Cell Rep. 2017;9:667&#x2013;680. doi: 10.1016/j.stemcr.2017.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.06.008</ArticleId><ArticleId IdType="pmc">PMC5549875</ArticleId><ArticleId IdType="pubmed">28712846</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang T.N., Lim N.K., Grubman A., Li Q.X., Volitakis I., White A.R., Crouch P.J. Increased metal content in the TDP-43(A315T) transgenic mouse model of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Front. Aging Neurosci. 2014;6:15. doi: 10.3389/fnagi.2014.00015.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2014.00015</ArticleId><ArticleId IdType="pmc">PMC3920072</ArticleId><ArticleId IdType="pubmed">24575040</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokuda E., Okawa E., Watanabe S., Ono S., Marklund S.L. Dysregulation of intracellular copper homeostasis is common to transgenic mice expressing human mutant superoxide dismutase-1s regardless of their copper-binding abilities. Neurobiol. Dis. 2013;54:308&#x2013;319. doi: 10.1016/j.nbd.2013.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2013.01.001</ArticleId><ArticleId IdType="pubmed">23321002</ArticleId></ArticleIdList></Reference><Reference><Citation>Felmus M.T., Patten B.M., Swanke L. Antecedent events in amyotrophic lateral sclerosis. Neurology. 1976;26:167&#x2013;172. doi: 10.1212/WNL.26.2.167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.26.2.167</ArticleId><ArticleId IdType="pubmed">946326</ArticleId></ArticleIdList></Reference><Reference><Citation>Roos P.M., Vesterberg O., Syversen T., Flaten T.P., Nordberg M. Metal concentrations in cerebrospinal fluid and blood plasma from patients with amyotrophic lateral sclerosis. Biol. Trace Elem. Res. 2013;151:159&#x2013;170. doi: 10.1007/s12011-012-9547-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12011-012-9547-x</ArticleId><ArticleId IdType="pubmed">23225075</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutedja N.A., Veldink J.H., Fischer K., Kromhout H., Heederik D., Huisman M.H., Wokke J.H., van den Berg L.H. Exposure to chemicals and metals and risk of amyotrophic lateral sclerosis: A systematic review. Amyotroph. Lateral Scler. 2009;10:302&#x2013;309. doi: 10.3109/17482960802455416.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960802455416</ArticleId><ArticleId IdType="pubmed">19922117</ArticleId></ArticleIdList></Reference><Reference><Citation>Roos P.M., Vesterberg O., Nordberg M. Metals in motor neuron diseases. Exp. Biol. Med. 2006;231:1481&#x2013;1487. doi: 10.1177/153537020623100906.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/153537020623100906</ArticleId><ArticleId IdType="pubmed">17018870</ArticleId></ArticleIdList></Reference><Reference><Citation>Roos P.M. Studies on Metals in Motor Neuron Disease. Karolinska Institutet; Solna, Sweden: 2013.</Citation></Reference><Reference><Citation>Peters T.L., Kamel F., Lundholm C., Feychting M., Weibull C.E., Sandler D.P., Wiebert P., Sparen P., Ye W., Fang F. Occupational exposures and the risk of amyotrophic lateral sclerosis. Occup. Environ. Med. 2017;74:87&#x2013;92. doi: 10.1136/oemed-2016-103700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/oemed-2016-103700</ArticleId><ArticleId IdType="pmc">PMC5451107</ArticleId><ArticleId IdType="pubmed">27418175</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton A. Lead Poisoning in Potteries, Tile Works, and Porcelain Enameled Sanitary Ware Factories. Bureau of Labor; Washington, DC, USA: 1912.</Citation></Reference><Reference><Citation>OSHA . Safety and Health Topics Lead. United States Department of Labor; Washington, DC, USA: 2021.</Citation></Reference><Reference><Citation>Bar-Sela S., Reingold S., Richter E.D. Amyotrophic lateral sclerosis in a battery-factory worker exposed to cadmium. Int. J. Occup. Environ. Health. 2001;7:109&#x2013;112. doi: 10.1179/oeh.2001.7.2.109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/oeh.2001.7.2.109</ArticleId><ArticleId IdType="pubmed">11373040</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachmeyer C., Bagur E., Lenglet T., Maier-Redelsperger M., Lecomte I. Lead poisoning mimicking amyotrophic lateral sclerosis: An adverse effect of rituals. Am. J. Med. 2012;125:e5&#x2013;e6. doi: 10.1016/j.amjmed.2011.11.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2011.11.030</ArticleId><ArticleId IdType="pubmed">22483060</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh S.S., Kim E.A., Lee S.W., Kim M.K., Kang S.K. A case of amyotrophic lateral sclerosis in electronic parts manufacturing worker exposed to lead. Neurotoxicology. 2007;28:324&#x2013;327. doi: 10.1016/j.neuro.2006.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2006.12.004</ArticleId><ArticleId IdType="pubmed">17374398</ArticleId></ArticleIdList></Reference><Reference><Citation>Roos E., W&#xe4;rml&#xe4;nder S., Meyer J., Sholts S.B., Jarvet J., Gr&#xe4;slund A., Roos P.M. Amyotrophic Lateral Sclerosis After Exposure to Manganese from Traditional Medicine Procedures in Kenya. Biol. Trace Elem. Res. 2021;199:3618&#x2013;3624. doi: 10.1007/s12011-020-02501-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12011-020-02501-4</ArticleId><ArticleId IdType="pmc">PMC8360856</ArticleId><ArticleId IdType="pubmed">33230634</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss H. Progressive bulbar paralysis and amyotrophic lateral sclerosis from chronic manganese poisoning. Arch. Gewerbepathol. Gewerbehyg. 1939;9:464&#x2013;476.</Citation></Reference><Reference><Citation>Bowman A.B., Kwakye G.F., Herrero Hernandez E., Aschner M. Role of manganese in neurodegenerative diseases. J. Trace Elem. Med. Biol. 2011;25:191&#x2013;203. doi: 10.1016/j.jtemb.2011.08.144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtemb.2011.08.144</ArticleId><ArticleId IdType="pmc">PMC3230726</ArticleId><ArticleId IdType="pubmed">21963226</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams C.R., Ziegler D.K., Lin J.T. Mercury intoxication simulating amyotrophic lateral sclerosis. JAMA. 1983;250:642&#x2013;643. doi: 10.1001/jama.1983.03340050054029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1983.03340050054029</ArticleId><ArticleId IdType="pubmed">6864963</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyser C.L., Kissel J.T., Mendell J.R. Three cases of amyotrophic lateral sclerosis in a common occupational environment. J. Neurol. 1987;234:443&#x2013;444. doi: 10.1007/BF00314096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00314096</ArticleId><ArticleId IdType="pubmed">3655851</ArticleId></ArticleIdList></Reference><Reference><Citation>Kantarjian A.D. A syndrome clinically resembling amyotrophic lateral sclerosis following chronic mercurialism. Neurology. 1961;11:639&#x2013;644. doi: 10.1212/WNL.11.7.639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.11.7.639</ArticleId><ArticleId IdType="pubmed">13751207</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanndag T., Ince D., Tekin S., Nourikhalichi K., Aktan S. ALS-like syndrome due to aluminium intoxication. Electroencephalogr. Clin. Neurophysiol. Electromyogr. Mot. Control. 1995;97:S229. doi: 10.1016/0924-980X(95)93292-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0924-980X(95)93292-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Chancellor A.M., Slattery J.M., Fraser H., Warlow C.P. Risk factors for motor neuron disease: A case-control study based on patients from the Scottish Motor Neuron Disease Register. J. Neurol. Neurosurg. Psychiatry. 1993;56:1200&#x2013;1206. doi: 10.1136/jnnp.56.11.1200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.56.11.1200</ArticleId><ArticleId IdType="pmc">PMC489821</ArticleId><ArticleId IdType="pubmed">8229031</ArticleId></ArticleIdList></Reference><Reference><Citation>Currier R.D., Haerer A.F. Amyotrophic lateral sclerosis and metallic toxins. Arch. Environ. Health. 1968;17:712&#x2013;719. doi: 10.1080/00039896.1968.10665310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00039896.1968.10665310</ArticleId><ArticleId IdType="pubmed">4879837</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A., Meineri P., Tribolo A., Schiffer D. Risk factors in motor neuron disease: A case-control study. Neuroepidemiology. 1991;10:174&#x2013;184. doi: 10.1159/000110267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000110267</ArticleId><ArticleId IdType="pubmed">1745327</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson F.O., Atchison W.D. The role of environmental mercury, lead and pesticide exposure in development of amyotrophic lateral sclerosis. Neurotoxicology. 2009;30:761&#x2013;765. doi: 10.1016/j.neuro.2009.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2009.07.010</ArticleId><ArticleId IdType="pmc">PMC2761528</ArticleId><ArticleId IdType="pubmed">19632272</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangelsdorf I., Walach H., Mutter J. Healing of Amyotrophic Lateral Sclerosis: A Case Report. Complement. Med. Res. 2017;24:175&#x2013;181. doi: 10.1159/000477397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000477397</ArticleId><ArticleId IdType="pubmed">28641283</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang F., Kwee L.C., Allen K.D., Umbach D.M., Ye W., Watson M., Keller J., Oddone E.Z., Sandler D.P., Schmidt S., et al. Association between blood lead and the risk of amyotrophic lateral sclerosis. Am. J. Epidemiol. 2010;171:1126&#x2013;1133. doi: 10.1093/aje/kwq063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwq063</ArticleId><ArticleId IdType="pmc">PMC2877471</ArticleId><ArticleId IdType="pubmed">20406759</ArticleId></ArticleIdList></Reference><Reference><Citation>Garzillo E.M., Lamberti M., Genovese G., Pedata P., Feola D., Sannolo N., Daniele L., Trojsi F., Monsurro M.R., Miraglia N. Blood lead, manganese, and aluminum levels in a regional Italian cohort of ALS patients: Does aluminum have an influence? J. Occup. Environ. Med. 2014;56:1062&#x2013;1066. doi: 10.1097/JOM.0000000000000266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JOM.0000000000000266</ArticleId><ArticleId IdType="pubmed">25285828</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinceti M., Solovyev N., Mandrioli J., Crespi C.M., Bonvicini F., Arcolin E., Georgoulopoulou E., Michalke B. Cerebrospinal fluid of newly diagnosed amyotrophic lateral sclerosis patients exhibits abnormal levels of selenium species including elevated selenite. Neurotoxicology. 2013;38:25&#x2013;32. doi: 10.1016/j.neuro.2013.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2013.05.016</ArticleId><ArticleId IdType="pmc">PMC3770807</ArticleId><ArticleId IdType="pubmed">23732511</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheykhansari S., Kozielski K., Bill J., Sitti M., Gemmati D., Zamboni P., Singh A.V. Redox metals homeostasis in multiple sclerosis and amyotrophic lateral sclerosis: A review. Cell Death Dis. 2018;9:348. doi: 10.1038/s41419-018-0379-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-0379-2</ArticleId><ArticleId IdType="pmc">PMC5832817</ArticleId><ArticleId IdType="pubmed">29497049</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Gall L., Anakor E., Connolly O., Vijayakumar U.G., Duddy W.J., Duguez S. Molecular and Cellular Mechanisms Affected in ALS. J. Pers. Med. 2020;10:101. doi: 10.3390/jpm10030101.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm10030101</ArticleId><ArticleId IdType="pmc">PMC7564998</ArticleId><ArticleId IdType="pubmed">32854276</ArticleId></ArticleIdList></Reference><Reference><Citation>Arvidson B. A review of axonal transport of metals. Toxicology. 1994;88:1&#x2013;14. doi: 10.1016/0300-483X(94)90107-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0300-483X(94)90107-4</ArticleId><ArticleId IdType="pubmed">8160191</ArticleId></ArticleIdList></Reference><Reference><Citation>Tjalve H., Henriksson J. Uptake of metals in the brain via olfactory pathways. Neurotoxicology. 1999;20:181&#x2013;195.</Citation><ArticleIdList><ArticleId IdType="pubmed">10385882</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordberg G., Fowler B.A., Nordberg M. Handbook on the Toxicology of Metals. 4th ed. Academic Press; London, UK: 2015.</Citation></Reference><Reference><Citation>Milton B., Krewski D., Mattison D.R., Karyakina N.A., Ramoju S., Shilnikova N., Birkett N., Farrell P.J., McGough D. Modeling U-shaped dose-response curves for manganese using categorical regression. Neurotoxicology. 2017;58:217&#x2013;225. doi: 10.1016/j.neuro.2016.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2016.10.001</ArticleId><ArticleId IdType="pubmed">27720796</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiina Y., Arima K., Tabunoki H., Satoh J. TDP-43 dimerizes in human cells in culture. Cell. Mol. Neurobiol. 2010;30:641&#x2013;652. doi: 10.1007/s10571-009-9489-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-009-9489-9</ArticleId><ArticleId IdType="pubmed">20043239</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.J., Caulfield T., Xu Y.F., Gendron T.F., Hubbard J., Stetler C., Sasaguri H., Whitelaw E.C., Cai S., Lee W.C., et al. The dual functions of the extreme N-terminus of TDP-43 in regulating its biological activity and inclusion formation. Hum. Mol. Genet. 2013;22:3112&#x2013;3122. doi: 10.1093/hmg/ddt166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt166</ArticleId><ArticleId IdType="pmc">PMC3699067</ArticleId><ArticleId IdType="pubmed">23575225</ArticleId></ArticleIdList></Reference><Reference><Citation>Francois-Moutal L., Perez-Miller S., Scott D.D., Miranda V.G., Mollasalehi N., Khanna M. Structural Insights Into TDP-43 and Effects of Post-translational Modifications. Front. Mol. Neurosci. 2019;12:301. doi: 10.3389/fnmol.2019.00301.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00301</ArticleId><ArticleId IdType="pmc">PMC6934062</ArticleId><ArticleId IdType="pubmed">31920533</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkins M.R., Gasteiger E., Bairoch A., Sanchez J.C., Williams K.L., Appel R.D., Hochstrasser D.F. Protein identification and analysis tools in the ExPASy server. Methods Mol. Biol. 1999;112:531&#x2013;552. doi: 10.1385/1-59259-584-7:531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/1-59259-584-7:531</ArticleId><ArticleId IdType="pubmed">10027275</ArticleId></ArticleIdList></Reference><Reference><Citation>Abraham D.J., Leo A.J. Extension of the fragment method to calculate amino acid zwitterion and side chain partition coefficients. Proteins. 1987;2:130&#x2013;152. doi: 10.1002/prot.340020207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prot.340020207</ArticleId><ArticleId IdType="pubmed">3447171</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang W.C., Lee M.H., Chen T.C., Huang J.R. Interactions between the Intrinsically Disordered Regions of hnRNP-A2 and TDP-43 Accelerate TDP-43&#x2032;s Conformational Transition. Int. J. Mol. Sci. 2020;21:5930. doi: 10.3390/ijms21165930.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21165930</ArticleId><ArticleId IdType="pmc">PMC7460674</ArticleId><ArticleId IdType="pubmed">32824743</ArticleId></ArticleIdList></Reference><Reference><Citation>Mompean M., Romano V., Pantoja-Uceda D., Stuani C., Baralle F.E., Buratti E., Laurents D.V. The TDP-43 N-terminal domain structure at high resolution. FEBS J. 2016;283:1242&#x2013;1260. doi: 10.1111/febs.13651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.13651</ArticleId><ArticleId IdType="pubmed">26756435</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo P.H., Doudeva L.G., Wang Y.T., Shen C.K., Yuan H.S. Structural insights into TDP-43 in nucleic-acid binding and domain interactions. Nucleic Acids Res. 2009;37:1799&#x2013;1808. doi: 10.1093/nar/gkp013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkp013</ArticleId><ArticleId IdType="pmc">PMC2665213</ArticleId><ArticleId IdType="pubmed">19174564</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukavsky P.J., Daujotyte D., Tollervey J.R., Ule J., Stuani C., Buratti E., Baralle F.E., Damberger F.F., Allain F.H. Molecular basis of UG-rich RNA recognition by the human splicing factor TDP-43. Nat. Struct. Mol. Biol. 2013;20:1443&#x2013;1449. doi: 10.1038/nsmb.2698.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2698</ArticleId><ArticleId IdType="pubmed">24240615</ArticleId></ArticleIdList></Reference><Reference><Citation>Afroz T., Hock E.M., Ernst P., Foglieni C., Jambeau M., Gilhespy L.A.B., Laferriere F., Maniecka Z., Pluckthun A., Mittl P., et al. Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation. Nat. Commun. 2017;8:45. doi: 10.1038/s41467-017-00062-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00062-0</ArticleId><ArticleId IdType="pmc">PMC5491494</ArticleId><ArticleId IdType="pubmed">28663553</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C.K., Wu T.H., Wu C.Y., Chiang M.H., Toh E.K., Hsu Y.C., Lin K.F., Liao Y.H., Huang T.H., Huang J.J. The N-terminus of TDP-43 promotes its oligomerization and enhances DNA binding affinity. Biochem. Biophys. Res. Commun. 2012;425:219&#x2013;224. doi: 10.1016/j.bbrc.2012.07.071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2012.07.071</ArticleId><ArticleId IdType="pubmed">22835933</ArticleId></ArticleIdList></Reference><Reference><Citation>Shodai A., Morimura T., Ido A., Uchida T., Ayaki T., Takahashi R., Kitazawa S., Suzuki S., Shirouzu M., Kigawa T., et al. Aberrant assembly of RNA recognition motif 1 links to pathogenic conversion of TAR DNA-binding protein of 43 kDa (TDP-43) J. Biol. Chem. 2013;288:14886&#x2013;14905. doi: 10.1074/jbc.M113.451849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.451849</ArticleId><ArticleId IdType="pmc">PMC3663511</ArticleId><ArticleId IdType="pubmed">23558684</ArticleId></ArticleIdList></Reference><Reference><Citation>Saini A., Chauhan V.S. Delineation of the core aggregation sequences of TDP-43 C-terminal fragment. ChemBioChem. 2011;12:2495&#x2013;2501. doi: 10.1002/cbic.201100427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbic.201100427</ArticleId><ArticleId IdType="pubmed">21905193</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C., Tan W., Whittle C., Qiu L., Cao L., Akbarian S., Xu Z. The C-terminal TDP-43 fragments have a high aggregation propensity and harm neurons by a dominant-negative mechanism. PLoS ONE. 2010;5:e15878. doi: 10.1371/journal.pone.0015878.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0015878</ArticleId><ArticleId IdType="pmc">PMC3013128</ArticleId><ArticleId IdType="pubmed">21209826</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L.L., Che M.X., Zhao J., Zhou C.J., Xie M.Y., Li H.Y., He J.H., Hu H.Y. Structural transformation of the amyloidogenic core region of TDP-43 protein initiates its aggregation and cytoplasmic inclusion. J. Biol. Chem. 2013;288:19614&#x2013;19624. doi: 10.1074/jbc.M113.463828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.463828</ArticleId><ArticleId IdType="pmc">PMC3707662</ArticleId><ArticleId IdType="pubmed">23689371</ArticleId></ArticleIdList></Reference><Reference><Citation>Roos P.M., Dencker L. Mercury in the spinal cord after inhalation of mercury. Basic Clin. Pharmacol. Toxicol. 2012;111:126&#x2013;132. doi: 10.1111/j.1742-7843.2012.00872.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-7843.2012.00872.x</ArticleId><ArticleId IdType="pubmed">22364490</ArticleId></ArticleIdList></Reference><Reference><Citation>Pamphlett R., Waley P. Uptake of inorganic mercury by the human brain. Acta Neuropathol. 1996;92:525&#x2013;527. doi: 10.1007/s004010050556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004010050556</ArticleId><ArticleId IdType="pubmed">8922066</ArticleId></ArticleIdList></Reference><Reference><Citation>Schionning J.D., Eide R., Moller-Madsen B., Ernst E. Detection of mercury in rat spinal cord and dorsal root ganglia after exposure to mercury vapor. Exp. Mol. Pathol. 1993;58:215&#x2013;228. doi: 10.1006/exmp.1993.1019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/exmp.1993.1019</ArticleId><ArticleId IdType="pubmed">8519348</ArticleId></ArticleIdList></Reference><Reference><Citation>Stankovic R. Atrophy of large myelinated motor axons and declining muscle grip strength following mercury vapor inhalation in mice. Inhal. Toxicol. 2006;18:57&#x2013;69. doi: 10.1080/08958370500282902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08958370500282902</ArticleId><ArticleId IdType="pubmed">16326402</ArticleId></ArticleIdList></Reference><Reference><Citation>Su M., Wakabayashi K., Kakita A., Ikuta F., Takahashi H. Selective involvement of large motor neurons in the spinal cord of rats treated with methylmercury. J. Neurol. Sci. 1998;156:12&#x2013;17. doi: 10.1016/S0022-510X(98)00030-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(98)00030-6</ArticleId><ArticleId IdType="pubmed">9559981</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarz S., Husstedt I., Bertram H.P., Kuchelmeister K. Amyotrophic lateral sclerosis after accidental injection of mercury. J. Neurol. Neurosurg. Psychiatry. 1996;60:698. doi: 10.1136/jnnp.60.6.698.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.60.6.698</ArticleId><ArticleId IdType="pmc">PMC1073965</ArticleId><ArticleId IdType="pubmed">8648348</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown I.A. Chronic mercurialism; a cause of the clinical syndrome of amyotrophic lateral sclerosis. AMA Arch. Neurol. Psychiatry. 1954;72:674&#x2013;681. doi: 10.1001/archneurpsyc.1954.02330060010002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurpsyc.1954.02330060010002</ArticleId><ArticleId IdType="pubmed">13206485</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber T.E. Inorganic mercury intoxication reminiscent of amyotrophic lateral sclerosis. J. Occup. Med. 1978;20:667&#x2013;669.</Citation><ArticleIdList><ArticleId IdType="pubmed">722351</ArticleId></ArticleIdList></Reference><Reference><Citation>Praline J., Guennoc A.M., Limousin N., Hallak H., de Toffol B., Corcia P. ALS and mercury intoxication: A relationship? Clin. Neurol. Neurosurg. 2007;109:880&#x2013;883. doi: 10.1016/j.clineuro.2007.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2007.07.008</ArticleId><ArticleId IdType="pubmed">17719172</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A., Bhardwaj V., Tiwari J.N., Patel D.K., Singh D.S., Singh R.L., Kalita J., Misra U.K., Babu G.N. Mercury exposure in sporadic amyotrophic lateral sclerosis patients from Ganga plain region in India: A retrospective study. Toxicol. Environ. Chem. 2010;92:373&#x2013;381. doi: 10.1080/02772240902846694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02772240902846694</ArticleId></ArticleIdList></Reference><Reference><Citation>Pamphlett R., Kum Jew S. Inorganic mercury within motor neurons does not cause the TDP-43 changes seen in sporadic ALS. Toxicol. Lett. 2011;201:58&#x2013;61. doi: 10.1016/j.toxlet.2010.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.toxlet.2010.12.005</ArticleId><ArticleId IdType="pubmed">21167262</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallin C., Friedemann M., Sholts S.B., Noormagi A., Svantesson T., Jarvet J., Roos P.M., Palumaa P., Gr&#xe4;slund A., W&#xe4;rml&#xe4;nder S.K.T.S. Mercury and Alzheimer&#x2019;s Disease: Hg(II) Ions Display Specific Binding to the Amyloid-beta Peptide and Hinder Its Fibrillization. Biomolecules. 2019;10:44. doi: 10.3390/biom10010044.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom10010044</ArticleId><ArticleId IdType="pmc">PMC7022868</ArticleId><ArticleId IdType="pubmed">31892131</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Z., Wu H., Zhao J. Multifunctional roles of zinc in Alzheimer&#x2032;s disease. Neurotoxicology. 2020;80:112&#x2013;123. doi: 10.1016/j.neuro.2020.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2020.07.003</ArticleId><ArticleId IdType="pubmed">32717200</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsvetkov P.O., Popov I.A., Nikolaev E.N., Archakov A.I., Makarov A.A., Kozin S.A. Isomerization of the Asp7 residue results in zinc-induced oligomerization of Alzheimer&#x2032;s disease amyloid beta(1&#x2013;16) peptide. ChemBioChem. 2008;9:1564&#x2013;1567. doi: 10.1002/cbic.200700784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbic.200700784</ArticleId><ArticleId IdType="pubmed">18506864</ArticleId></ArticleIdList></Reference><Reference><Citation>Garnier C., Devred F., Byrne D., Puppo R., Roman A.Y., Malesinski S., Golovin A.V., Lebrun R., Ninkina N.N., Tsvetkov P.O. Zinc binding to RNA recognition motif of TDP-43 induces the formation of amyloid-like aggregates. Sci. Rep. 2017;7:6812. doi: 10.1038/s41598-017-07215-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-07215-7</ArticleId><ArticleId IdType="pmc">PMC5533730</ArticleId><ArticleId IdType="pubmed">28754988</ArticleId></ArticleIdList></Reference><Reference><Citation>Gade Malmos K., Blancas-Mejia L.M., Weber B., Buchner J., Ramirez-Alvarado M., Naiki H., Otzen D. ThT 101: A primer on the use of thioflavin T to investigate amyloid formation. Amyloid. 2017;24:1&#x2013;16. doi: 10.1080/13506129.2017.1304905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13506129.2017.1304905</ArticleId><ArticleId IdType="pubmed">28393556</ArticleId></ArticleIdList></Reference><Reference><Citation>Golovin A.V., Devred F., Yatoui D., Roman A.Y., Zalevsky A.O., Puppo R., Lebrun R., Guerlesquin F., Tsvetkov P.O. Zinc Binds to RRM2 Peptide of TDP-43. Int. J. Mol. Sci. 2020;21:9080. doi: 10.3390/ijms21239080.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21239080</ArticleId><ArticleId IdType="pmc">PMC7730363</ArticleId><ArticleId IdType="pubmed">33260324</ArticleId></ArticleIdList></Reference><Reference><Citation>Winterbourn C.C. Toxicity of iron and hydrogen peroxide: The Fenton reaction. Toxicol. Lett. 1995;82&#x2013;83:969&#x2013;974. doi: 10.1016/0378-4274(95)03532-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0378-4274(95)03532-X</ArticleId><ArticleId IdType="pubmed">8597169</ArticleId></ArticleIdList></Reference><Reference><Citation>Meloni G., Faller P., Vasak M. Redox silencing of copper in metal-linked neurodegenerative disorders: Reaction of Zn7metallothionein-3 with Cu2+ ions. J. Biol. Chem. 2007;282:16068&#x2013;16078. doi: 10.1074/jbc.M701357200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M701357200</ArticleId><ArticleId IdType="pubmed">17389590</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker S.J., Meyerowitz J., James J.L., Liddell J.R., Nonaka T., Hasegawa M., Kanninen K.M., Lim S., Paterson B.M., Donnelly P.S., et al. Inhibition of TDP-43 accumulation by bis(thiosemicarbazonato)-copper complexes. PLoS ONE. 2012;7:e42277. doi: 10.1371/journal.pone.0042277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0042277</ArticleId><ArticleId IdType="pmc">PMC3411774</ArticleId><ArticleId IdType="pubmed">22879928</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitani T.T., Beck G., Kido K., Yamashita R., Yonenobu Y., Ogawa T., Saeki C., Okuno T., Nagano S., Morii E., et al. Amyotrophic lateral sclerosis with speech apraxia, predominant upper motor neuron signs, and prominent iron accumulation in the frontal operculum and precentral gyrus. Neuropathology. 2021;41:324&#x2013;331. doi: 10.1111/neup.12763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/neup.12763</ArticleId><ArticleId IdType="pubmed">34219295</ArticleId></ArticleIdList></Reference><Reference><Citation>Roos P.M., Lierhagen S., Flaten T.P., Syversen T., Vesterberg O., Nordberg M. Manganese in cerebrospinal fluid and blood plasma of patients with amyotrophic lateral sclerosis. Exp. Biol. Med. 2012;237:803&#x2013;810. doi: 10.1258/ebm.2012.011396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1258/ebm.2012.011396</ArticleId><ArticleId IdType="pubmed">22859739</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo J., Warmlander S.K., Graslund A., Abrahams J.P. Human lysozyme inhibits the in vitro aggregation of Abeta peptides, which in vivo are associated with Alzheimer&#x2019;s disease. Chem. Commun. 2013;49:6507&#x2013;6509. doi: 10.1039/c3cc42325e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c3cc42325e</ArticleId><ArticleId IdType="pubmed">23764522</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo J., Warmlander S.K., Graslund A., Abrahams J.P. Non-chaperone proteins can inhibit aggregation and cytotoxicity of Alzheimer amyloid beta peptide. J. Biol. Chem. 2014;289:27766&#x2013;27775. doi: 10.1074/jbc.M114.574947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.574947</ArticleId><ArticleId IdType="pmc">PMC4183812</ArticleId><ArticleId IdType="pubmed">25100721</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo J., Warmlander S.K., Graslund A., Abrahams J.P. Reciprocal Molecular Interactions between the Abeta Peptide Linked to Alzheimer&#x2032;s Disease and Insulin Linked to Diabetes Mellitus Type II. ACS Chem. Neurosci. 2016;7:269&#x2013;274. doi: 10.1021/acschemneuro.5b00325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.5b00325</ArticleId><ArticleId IdType="pubmed">26785771</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallin C., Hiruma Y., Warmlander S., Huvent I., Jarvet J., Abrahams J.P., Graslund A., Lippens G., Luo J. The Neuronal Tau Protein Blocks in Vitro Fibrillation of the Amyloid-beta (Abeta) Peptide at the Oligomeric Stage. J. Am. Chem. Soc. 2018;140:8138&#x2013;8146. doi: 10.1021/jacs.7b13623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jacs.7b13623</ArticleId><ArticleId IdType="pubmed">29708745</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallin C., Kulkarni Y.S., Abelein A., Jarvet J., Liao Q., Strodel B., Olsson L., Luo J., Abrahams J.P., Sholts S.B., et al. Characterization of Mn(II) ion binding to the amyloid-beta peptide in Alzheimer&#x2032;s disease. J. Trace Elem. Med. Biol. 2016;38:183&#x2013;193. doi: 10.1016/j.jtemb.2016.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtemb.2016.03.009</ArticleId><ArticleId IdType="pubmed">27085215</ArticleId></ArticleIdList></Reference><Reference><Citation>Gielnik M., Pietralik Z., Zhukov I., Szymanska A., Kwiateke W.M., Kozak M. PrP (58&#x2013;93) peptide from unstructured N-terminal domain of human prion protein forms amyloid-like fibrillar structures in the presence of Zn2+ ions. RSC Adv. 2019;9:22211&#x2013;22219. doi: 10.1039/C9RA01510H.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C9RA01510H</ArticleId></ArticleIdList></Reference><Reference><Citation>Gielnik M., Taube M., Zhukova L., Zhukov I., W&#xe4;rml&#xe4;nder S.K.T.S., Svedru&#x17e;i&#x107; &#x17d;., Kwiatek W.M., Gr&#xe4;slund A., Kozak M. Zn(II) binding causes interdomain changes in the structure and flexibility of the human prion protein. Sci. Rep. 2021;11:21703. doi: 10.1038/s41598-021-00495-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-00495-0</ArticleId><ArticleId IdType="pmc">PMC8568922</ArticleId><ArticleId IdType="pubmed">34737343</ArticleId></ArticleIdList></Reference><Reference><Citation>Abelein A., Gr&#xe4;slund A., Danielsson J. Zinc as chaperone-mimicking agent for retardation of amyloid beta peptide fibril formation. Proc. Natl. Acad. Sci. USA. 2015;112:5407&#x2013;5412. doi: 10.1073/pnas.1421961112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1421961112</ArticleId><ArticleId IdType="pmc">PMC4418866</ArticleId><ArticleId IdType="pubmed">25825723</ArticleId></ArticleIdList></Reference><Reference><Citation>Faller P., Hureau C. Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-beta peptide. Dalton Trans. 2009;7:1080&#x2013;1094. doi: 10.1039/B813398K.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/B813398K</ArticleId><ArticleId IdType="pubmed">19322475</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson J.L., Geser F., Stieber A., Umoh M., Kwong L.K., Van Deerlin V.M., Lee V.M., Trojanowski J.Q. TDP-43 skeins show properties of amyloid in a subset of ALS cases. Acta Neuropathol. 2013;125:121&#x2013;131. doi: 10.1007/s00401-012-1055-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1055-8</ArticleId><ArticleId IdType="pmc">PMC3536927</ArticleId><ArticleId IdType="pubmed">23124365</ArticleId></ArticleIdList></Reference><Reference><Citation>White A.R., Aschner M., Costa L.G., Bush A.I. Biometals in Neurodegenerative Diseases: Mechanisms and Therapeutics. Elsevier Science &amp; Technology; San Diego, CA, USA: 2017.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>